Sonoma Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/07/2025 | 20.87 K | $80.99 K | 100.00% | 1.27% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 17.62 K | $68.35 K | 0.00% | 1.07% |
| DRW SECURITIES, LLC | 11/14/2025 | 17.07 K | $66.23 K | 100.00% | 1.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 1.54 K | $5.96 K | 53.60% | 0.09% |
| CITIGROUP INC | 11/10/2025 | 656 | $2.55 K | 100.00% | 0.04% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 11/14/2025 | 646 | $2.51 K | 100.00% | 0.04% |
| GLOBAL RETIREMENT PARTNERS, LLC | 10/21/2025 | 438 | $1.70 K | 100.00% | 0.03% |
| MAI CAPITAL MANAGEMENT | 11/10/2025 | 124 | $482 | 100.00% | 0.01% |
| JPMORGAN CHASE & CO | 11/26/2025 | 123 | $477 | 2.50% | 0.01% |
| BLACKROCK, INC. | 11/12/2025 | 113 | $438 | 0.00% | 0.01% |
| UBS GROUP AG | 11/13/2025 | 108 | $419 | -99.25% | 0.01% |
| US BANCORP \DE\ | 11/12/2025 | 25 | $97 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 17 | $66 | 0.00% | 0.00% |
| MORGAN STANLEY | 11/14/2025 | 4 | $16 | 0.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 12/02/2025 | 3 | $12 | 0.00% | 0.00% |
| QUAKER WEALTH MANAGEMENT, LLC | 11/05/2025 | 3 | $12 | 0.00% | 0.00% |
| FMR LLC | 11/13/2025 | 2 | $7 | 100.00% | 0.00% |
| DANSKE BANK A/S | 11/19/2025 | 1 | $4 | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 1 | $4 | 100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| HERON BAY CAPITAL MANAGEMENT | 11/12/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Sonoma Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 23 institutional investors and hedge funds held shares of Sonoma Pharmaceuticals, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 20,873
GEODE CAPITAL MANAGEMENT, LLC: 17,617
DRW Securities, LLC: 17,070
Tower Research Capital LLC (TRC): 1,536
CITIGROUP INC: 656
Rockefeller Capital Management L.P.: 646
3.62% of Sonoma Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 61.79 K shares in the last 24 months. This purchase volume represents approximately $246.55 K in transactions.